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Abstract. 
 
Vascular endothelial growth factor (VEGF) 
is a key regulator of endothelial growth and permeabil-
ity. However, VEGF may also target nonendothelial 
cells, as VEGF receptors and responsiveness have been 
detected for example in monocytes, and high concen-
trations of VEGF have been reported in human semen. 
In this work we present evidence that overexpression of 
VEGF in the testis and epididymis of transgenic mice 
under the mouse mammary tumor virus (MMTV) LTR 
promoter causes infertility. The testes of the transgenic 
mice exhibited spermatogenic arrest and increased cap-
illary density. The ductus epididymidis was dilated, 
containing areas of epithelial hyperplasia. The number 
of subepithelial capillaries in the epididymis was also 
increased and these vessels were highly permeable as 
judged by the detection of extravasated fibrinogen 
products. Intriguingly, the expression of VEGF recep-
tor-1 (VEGFR-1) was detected in certain spermato-
genic cells in addition to vascular endothelium, and 
both VEGFR-1 and VEGFR-2 were also found in the 
Leydig cells of the testis. The infertility of the MMTV-
VEGF male mice could thus result from VEGF acting 
on both endothelial and nonendothelial cells of the 
male genital tract. Taken together, these findings sug-
gest that the VEGF transgene has nonendothelial tar-
get cells in the testis and that VEGF may regulate male 
fertility.
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V
 
ascular 
 
endothelial growth factor (VEGF
 
)
 
1 
 
is a
major regulator of blood vessel growth and perme-
ability (for review see ref. 13). Its essential role in
the development of the vasculature is emphasized by the
finding that the loss of even a single VEGF allele results
in embryonic lethality (5, 11). VEGF is also important
during postnatal life in physiological angiogenic processes
such as corpus luteum vascularization (12), and it has been
strongly implicated in tumor angiogenesis. VEGF stimu-
lates several stages of blood vessel formation including en-
dothelial degradation of the underlying basement mem-
brane, migration into the surrounding tissue, proliferation,
and tube formation. It also acts as a survival factor for
newly formed vessels (2). VEGF exerts its activities through
binding to two receptor tyrosine kinases, VEGFR-1 (Flt-1)
and VEGFR-2 (KDR/Flk-1). These receptors are ex-
pressed almost exclusively on endothelial cells, with a few
exceptions such as VEGFR-1 in monocytes where it me-
diates chemotaxis (1, 7). Despite their structural similar-
ity, the two VEGF receptors are functionally different:
VEGFR-2 is required for the development of the endothe-
lial lineage whereas VEGFR-1 plays a role in the organi-
zation of the vascular endothelium (14, 29). In vitro exper-
iments have indicated that VEGF-induced proliferation is
mainly mediated by VEGFR-2, whereas VEGFR-1 may be
capable of mediating a migratory response (1, 7, 28, 31).
Recent findings have alluded to a novel role for VEGF
in male fertility. VEGF has been shown to be expressed by
several cell types in the male genital tract including Leydig
and Sertoli cells of the testis, certain epithelial cells and
peritubular cells of the epididymis, and the epithelium of
the prostate and seminal vesicle (4, 9, 10). Concentration
of VEGF in semen is very high, 
 
z
 
300 pM, which is well
above the levels measured in tumor effusions or serum (4).
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The target cells and exact role of VEGF in the male geni-
tal tract are currently unknown. Both types of VEGFRs
are expressed in testicular microvasculature and VEGFR-2
has been detected also in vascular endothelium of the epi-
didymis (9, 10). The function of VEGF in the testis and
epididymis may be associated with vascular permeability,
as neither of these tissues are sites of active angiogenesis
in the adult. Indeed, topical application of VEGF into the
epididymis has been recently shown to induce fenestra-
tions and transendothelial gaps in capillaries (10).
To investigate the effects of VEGF in vivo, we have
generated transgenic mice expressing VEGF under the
mouse mammary tumor virus (MMTV) LTR promoter.
The MMTV promoter has been widely used to target
transgene expression into the mammary gland, but it has
been reported to be active also in certain other tissues in-
cluding testis, epididymis, seminal vesicle, and prostate (3,
15). Transcriptional activity of MMTV is induced by ste-
roid hormones including glucocorticoids, progestins, an-
drogens, and mineralocorticoids, and prolactin also con-
tributes to high expression (for review see ref. 15). In this
study we have investigated the effect of MMTV LTR-
driven VEGF overexpression in the testis and epididymis.
Analysis of the mammary gland phenotype of MMTV-
VEGF female mice will be presented elsewhere.
 
Materials and Methods
 
Generation of the MMTV-hVEGF165 Transgenic Mice
 
The MMTV-hVEGF165 transgene vector was constructed by cloning the
MMTV-LTR sequence from pA9 (19) as a BamHI-BglII fragment into
pGEM3Zf(
 
1
 
) (Promega, Madison, WI). hVEGF-165 cDNA (bp 57Ð638
[22]) was then added as a BamHI fragment. Finally, the bovine growth
hormone polyadenylation signal was PCR amplified from pcDNA3 (Invi-
trogen, Carlsbad, CA) and cloned as an EcoRI fragment into the vector.
A HindIII-NdeI fragment of the resulting construct was microinjected
into fertilized oocytes of the FVB/N strain of mice, and the injected zy-
gotes were transplanted into oviducts of pseudopregnant C57BL/6xDBA/
2J hybrid mice. The resulting founder mice were analyzed for the pres-
ence of the transgene by PCR of tail DNA using primers 5
 
9
 
-CTGCA-
GATATCCATCACACTGG-3
 
9
 
 and 5
 
9
 
-ACCTACTCAGACAATGC-
GATGC-3
 
9
 
. The tail DNAs were also subjected to endonuclease
digestion, Southern blotting, and hybridization analysis using the hVEGF-
165 cDNA fragment as the probe.
 
RNA Isolation and Northern Blot Analysis
 
For total RNA preparation, tissues were frozen in liquid nitrogen, pul-
verized with Mikro-Dismembrator U (B. Braun Biotech International,
Melsungen, Germany) and the RNA was isolated using the guanidium
thiocyanate-method (6). 10 
 
m
 
g total RNA samples were size fractionated
on 1.0% formaldehyde-agarose gels, transferred to Nytran
 
¨ 
 
nylon mem-
brane (Schleicher & Schuell, Dassel, Germany), UV cross-linked, and
then hybridized with the hVEGF-165 cDNA probe. The rGAPDH cDNA
probe was used as an internal control for equal loading. The probes were
labeled with [
 
a
 
32
 
P]dCTP (3,000 Ci/mmol; Amersham Int. plc, Bucking-
hamshire, UK) by random priming. Prehybridizations and hybridizations
were performed at 42
 
8
 
C in a solution containing 50% formamide, 5
 
3
 
Denhardt solution, 5
 
3 
 
SSPE, 0.5% SDS, and 200 
 
m
 
g/ml salmon sperm
DNA. The filters were washed once for 30 min at room temperature and
twice for 10 min at 65
 
8
 
C with 1
 
3 
 
SSC, 0.1% SDS, and then exposed to Fuji
Medical X-ray film after quantitation by phosphorimager analysis (Bio-
Imaging Analyzer BAS1500; Fuji, Tokyo, Japan).
 
In Situ Hybridization
 
For in situ analysis the tissues were fixed in paraformaldehyde overnight
(o/n) at 4
 
8
 
C and dehydrated in an increasing ethanol series followed by xy-
lene and then embedded in paraffin. 6-
 
m
 
m sections were placed on a layer
of diethyl pyrocarbonate-treated water on the surface of glass slides pre-
treated with 2% 2-aminopropyltriethoxysilane. The antisense and sense
hVEGF cRNA probes were synthesized from linearized pGEM-3Zf(
 
1
 
)
plasmids containing the hVEGF cDNA insert in both orientations, using
T7 polymerase and [
 
35
 
S]dUTP (Amersham). The template for mVEGFR-1
probe containing the bp 1,438Ð2,090 of the mVEGFR-1 (GenBank/
EMBL/DDBJ accession number L07297) was generated by PCR and
cloned into pCR2.1-TOPO vector (Invitrogen) in both orientations. Anti-
sense and sense probes were generated using T7 polymerase. The
mVEGFR-2 probes were prepared as previously described (20). In situ
hybridization was performed according to Wilkinson et al. (33, 34) with
the following modifications: the sections were treated with 10 
 
m
 
g/ml of
proteinase K for 15 min at room temperature (RT), the alkaline hydroly-
sis of the probes was omitted, and the high stringency wash was for 60 min
in 65
 
8
 
C in a solution containing 30 mM DTT, 2
 
3 
 
SSC, and 50% deionized
formamide. The sections were covered with NTB-2 emulsion (Eastman-
Kodak, Rochester, NY), exposed at 4
 
8
 
C for 35 d, developed, and then
stained with hematoxylin.
 
Immunohistochemistry
 
For immunohistochemical analysis the tissues were fixed in paraformalde-
hyde for 15 h at 4
 
8
 
C and embedded in paraffin after dehydration. 4-
 
m
 
m
sections were deparaffinized, dehydrated, and then incubated with 0.25
mg/ml trypsin (Difco, Detroit, MI) in 0.05 M Tris buffer, pH 7.8, contain-
ing 9 mM CaCl
 
2
 
 for 20 min at 37
 
8
 
C for antigen retrieval before the block-
ing of the endogenous peroxidase activity with 3% H
 
2
 
O
 
2
 
 in methanol for
10 min at RT. The immunohistochemical staining for von Willebrand Fac-
tor (vWF) was done using the Tyramide Signal Amplification system
(TSA
 
¨
 
; New England Nuclear Life Science Products, Boston, MA) ac-
cording to the manufacturerÕs instructions. The sections were incubated
with 7.5 
 
m
 
g/ml polyclonal rabbit anti-hvWF antibody (Ab) (A0082; Dako,
Carpinteria, CA) at 4
 
8
 
C o/n. For negative controls the section was incu-
bated in the blocking reagent without the primary Ab. The incubation
with the secondary Ab was for 30 min at RT with 7.5 
 
m
 
g/ml of biotinylated
goat antiÐrabbit IgG (Vector Laboratories, Burlingame, CA). After the
amplification steps the peroxidase activity was developed with 3-amino-
9-ethyl carbazole (Sigma Chemical Co., St. Louis, MO) in 0.05 M sodium
acetate buffer, pH 5.0, and the sections were counterstained with hema-
toxylin. The testicular capillaries stained for vWF were counted from 10
high-power microscopic fields. The average numbers and standard devia-
tions were then derived from the analysis of three transgenic and control
mice. Immunohistochemical detection of fibrinogen and its degradation
products was performed similarly except that 10% goat serum was used
for blocking and the polyclonal rabbit anti-human fibrinogen Ab (A0080;
Dako) was used as the primary Ab at 9 
 
m
 
g/ml. Instead of the TSA amplifi-
cation method, the sections were incubated for 30 min at RT with the
Vectastain Elite ABC reagent (Vector Laboratories) before the color de-
velopment.
 
Analysis of the Seminiferous Tubules by 
Transillumination and Squash Preparations
 
Seminiferous tubules were dissected and photographed under a transillu-
mination dissection microscope, and the spermatogenic cells were identi-
fied from live cell squash preparations (25).
 
Results
 
MMTV-VEGF Transgenic Male Mice Are Infertile
 
To study the effect of VEGF overexpression in transgenic
mice, the cDNA coding for the 165-amino acid isoform of
hVEGF was expressed under the MMTV promoter. Nine
different MMTV-VEGF transgenic lines were obtained,
with copy numbers ranging from 
 
,
 
1 (mosaic) to 18 as
judged by Southern blotting (data not shown). The MMTV-
VEGF mice appeared healthy and did not exhibit any
macroscopic physical aberrations or reduction in body
weight. To confirm transgene expression, RNA samples
from different tissues were analyzed by Northern blotting 
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(Fig. 1). As expected, high levels of the VEGF transgene
mRNA were detected in mammary glands of lactating fe-
males. Interestingly, the transgene was expressed at com-
parable levels in the epididymis and to a lesser extent in
the testis, whereas no expression was detected in the pros-
tate (Fig. 1) or seminal vesicle (data not shown).
As studies on human testis and epididymis have recently
suggested that VEGF may have a role in the male repro-
ductive tract (4, 9, 10), we investigated the effect of VEGF
overexpression on the fertility of the MMTV-VEGF mice.
MMTV-VEGF males of five transgenic lines which dif-
fered in their level of transgene expression in the epididy-
mis as judged by Northern blotting (data not shown) were
kept in continuous breeding from 8 wk to 6 mo of age.
Strikingly, the MMTV-VEGF males sired no offspring
during this period, whereas other transgenic and nontrans-
genic mice as well as MMTV-VEGF females in the same
facility reproduced normally.
 
The Ductus Epididymidis of MMTV-VEGF Mice Is 
Dilated and Hyperplastic
 
Comparison of the 6-mo-old MMTV-VEGF males with
their wild-type (WT) littermates indicated that their epi-
didymides were enlarged and swollen, whereas no appar-
ent differences in testes, prostate, seminal vesicle, or other
internal organs were observed. Histological examination
(Fig. 2, 
 
AÐE
 
) confirmed that the ductus epididymidis was
dilated, especially in caput and corpus epididymidis. The
epithelium of the caput epididymidis was reduced in
height, reminiscent of that found normally in the cauda re-
gion. The connective tissue septa between the segments
contained enlarged blood vessels. All transgenic animals
exhibited epithelial hyperproliferation dividing the duct
into multiple narrow sublumens in proximal cauda epi-
didymidis, and in some animals hyperplasia was observed
also in the caput region. These hyperplastic areas were in-
terspersed and surrounded by an increased number of sub-
epithelial capillaries as evidenced by the presence of red
cells and the vWF staining of the endothelial cells (Fig. 2,
 
E 
 
and
 
 F)
 
. Staining using antibodies to fibrinogen, which
has been used to detect increased capillary permeability
resulting in fibrin deposition in tissues (24), indicated leak-
age of this plasma protein in between the epithelial cells
and on the luminal side of the ductal epithelium (Fig. 2, 
 
G
 
and
 
 H
 
). Spermatozoa could be seen only in some ductal
sections preceding the hyperplastic zones.
 
VEGF Overexpression in the Ductal Epithelium 
Upregulates the Expression of VEGFRs
 
Expression the VEGF transgene in the epididymis was
further localized by in situ hybridization. As shown in Fig.
2 
 
I
 
, VEGF mRNA was strongly expressed in the epithe-
lium of the ductus epididymidis, the proximal caput epidid-
ymidis and the hyperplastic areas of cauda epididymidis
showing the highest level of transgene expression. To
investigate the possible target cells for VEGF, in situ hy-
bridization was performed using VEGFR-1 (Flt-1) and
VEGFR-2 (Flk-1) riboprobes. In WT control mice, VEGFR-1
was expressed in the endothelium of the interstitial blood
vessels throughout the epididymis, whereas no expression
of VEGFR-2 could be detected (Fig. 2, 
 
N 
 
and 
 
L
 
). In con-
trast, both receptors were strongly upregulated in the epi-
didymides of TG animals (Fig. 2, 
 
K 
 
and 
 
M
 
). Their expres-
sion followed closely that of VEGF, but the patterns were
not overlapping: whereas VEGF was confined to the inner
epithelium of the duct, the receptors were expressed in the
outer rim. This difference was clearly visible in the hyper-
plastic areas where the receptor signals could be seen also
in presumptive endothelial cells inside the hyperplastic
nodules, surrounded by the epithelial VEGF signal.
VEGFR-1 expression in the walls of the interstitial blood
vessels was similar to that in the WT animals.
 
Aberrant Spermatogenesis in MMTV-VEGF Mice
 
Because of the lack of spermatozoa in the ductus epididy-
midis, the testes of MMTV-VEGF males were analyzed in
detail. The seminiferous tubules were first examined in
freshly isolated living condition by transillumination. Since
tubular segments containing maturation phase spermatids
appear dark due to the DNA compaction, this technique
can be used to obtain a rapid overview of the spermato-
genic development (25). Although the MMTV-VEGF mice
had some normal-looking tubules, the majority of the tu-
bules appeared homogeneously pale, lacking the normal
spermatogenic wave (Fig. 3, 
 
top
 
). Squash preparations of
these segments demonstrated that spermatogenesis was
interrupted at the elongation phase of the spermatids (Fig.
3, 
 
bottom
 
). Neither elongated spermatids or spermatozoa
were observed, but somatic Sertoli cells, spermatogonia,
meiotic cells, and round spermatids appeared normal. We
also observed many phase-negative cellular spheres, which
have been shown to correspond to apoptotic bodies (16).
Some tubules contained heavily light absorbing material
Figure 1. Expression of the VEGF transgene mRNA in the epi-
didymis and testis. Total RNA was prepared from the testis, epi-
didymis, and prostate of MMTV-VEGF transgenic mice and WT
control mice and then 10-mg samples were analyzed by Northern
blotting using the hVEGF-165 cDNA fragment as a probe (top).
Mammary gland (MG) RNA of MMTV-VEGF female mice was
used as a positive control. Signals corresponding to the VEGF
transgene mRNA (TG VEGF) and the endogenous mouse
VEGF mRNA are shown. The filter was stripped and reprobed
for GAPDH to check RNA loading (bottom). 
The Journal of Cell Biology, Volume 143, 1998 1708
 
Figure 2.
 
Histological comparison of epididymides of 6-mo-old MMTV-VEGF transgenic and WT control mice (
 
AÐH
 
), and localization
of expression of the VEGF transgene and VEGFRs by in situ hybridization (
 
IÐN
 
). The ductus epididymidis of TG mice is dilated and
devoid of spermatozoa in the caput region (
 
A
 
) and exhibits epithelial hyperplasia in the cauda epididymidis (
 
C
 
). Caput and cauda epi-
didymidis of a WT control mouse are shown in 
 
B 
 
and 
 
D
 
, respectively. Higher magnification of the hyperplastic epithelium in the cauda
epididymidis of the MMTV-VEGF mice (
 
E
 
) reveals the presence of interspersed capillaries (
 
arrows
 
). Immunohistochemical staining of
these capillaries for vWF is shown in 
 
F
 
. The fibrinogen staining in the same area (
 
G
 
) indicates that the capillary permeability is in- 
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that appeared to have a very hard consistency, which did
not permit a normal analysis of living cells in the squash
preparations (Fig. 3, 
 
top
 
).
Histological analysis of the testes of the 6-mo-old MMTV-
VEGF mice confirmed that whereas some seminiferous
tubules appeared relatively normal, others contained vac-
uoles and disorganized seminiferous epithelium with few
spermatogenic cells (Fig. 4, 
 
AÐD
 
). The absence of devel-
oping spermatids and spermatozoa was clear and numer-
ous degenerating cells were observed in the atrophic tu-
bules. In contrast, the somatic Sertoli and Leydig cells
appeared normal. The rete testis was remarkably dilated
in the transgenic animals when compared with that of the
WT controls. The capillary density was increased by 60 
 
6
 
20% as judged by counting of blood vessels in sections
stained for the vWF. Also, many of the capillaries of the
TG testes were enlarged when compared with the con-
trols.
 
Expression of the VEGF Transgene in Spermatogenic 
Cells and VEGFRs in Nonendothelial Cells
 
The sites of VEGF transgene expression in the testis were
localized by in situ hybridization. The VEGF signal was
found inside the seminiferous tubules and it seemed to be
restricted to step 1Ð12 spermatids, whereas no expression
was observed in the Sertoli cells (Fig. 4, 
 
EÐG
 
). VEGFR
expression was subsequently studied by in situ hybridiza-
tion in order to identify potential VEGF-responsive cells.
Testes of WT control mice showed no hybridization with
the VEGFR-2 riboprobe but, interestingly, strong VEGFR-1
signals were observed in stage VIII seminiferous tubules
(Fig. 4, 
 
KÐM
 
). In these tubules the grains accumulated
specifically over midpachytene spermatocytes and round
(step 8) spermatids. In MMTV-VEGF mice, low levels of
VEGFR-1 signal were seen also in round spermatids of
the other stages. Interestingly, the expression of both
VEGFR-1 and -2 was strongly upregulated in the intersti-
tial tissue of the testes of TG animals (Fig. 4, 
 
HÐJ 
 
and 
 
N
 
).
Careful analysis of the VEGFR signals in brightfield mi-
croscopy showed that the majority of the in situ silver
grains were localized in nonendothelial cells identified as
Leydig cells by their morphology and location (Fig. 4 
 
J
 
).
 
Discussion
 
In this work we present evidence that overexpression of
VEGF in the testis and epididymis of transgenic mice un-
der the MMTV promoter leads to upregulation of VEGF
receptors in the endothelial cells, in certain spermatogenic
cells, and in the Leydig cells, and causes infertility. The
testes of MMTV-VEGF mice exhibited spermatogenic ar-
rest and the ductus epididymidis was dilated, containing
areas of epithelial hyperplasia. Although some of these ef-
fects are likely to be due to the action of VEGF on the vas-
cular endothelium, our data suggests that VEGF may act
also directly on nonendothelial cells including the Leydig
cells and certain spermatogenic cells.
The MMTV-driven VEGF transgene was found to be
expressed in round spermatids in seminiferous tubules and
in the ductal epithelium of the epididymis. Although the
latter finding conforms with the inducibility of the MMTV
LTR promoter by androgens, the expression in step 1Ð12
spermatids (and not, for example, in Sertoli cells) is some-
what surprising as the androgen receptor is expressed in
Sertoli cells at stages IVÐVIII of the cycle, and in elongat-
ing step 11 spermatids in rat seminiferous epithelium (32).
In mice, spermatogonia have also been reported to contain
androgen receptors (36). The glucocorticoid receptor which
could also potentially activate the MMTV LTR has only
been observed in primary spermatocytes (27). To our
knowledge the MMTV LTR transcriptional activity has
not been previously localized by in situ
 
 
 
hybridization in
the testis (or epididymis), and the results presented here
suggest that the regulation of the MMTV LTR is more
complex than previously appreciated.
Interestingly, the expression of VEGFRs was not re-
stricted to the vascular endothelium of the testis and epi-
didymis (Table I). VEGFR-1 was expressed in stage VIII
seminiferous tubules where it localized to midpachytene
spermatocytes and round spermatids as judged by in
situ hybridization. In MMTV-VEGF mice, low levels of
VEGFR-1 signal were seen also in the round spermatids
of other stages. Furthermore, both VEGFR-1 and -2 were
observed in the Leydig cells in the MMTV-VEGF mice,
 
creased in the TG mice when compared with the WT mice (
 
H
 
). 
 
Asterisks
 
, lumen of the ductus epididymidis. The VEGF transgene is ex-
pressed in the ductal epithelium (
 
arrowhead
 
) as judged by in situ hybridization (
 
I
 
, antisense and 
 
J
 
, sense hVEGF probe). In contrast, the
VEGFR-2 antisense probe localizes to the outer rim of the duct (
 
arrowhead
 
) and inside the hyperplastic nodules in cauda epididymidis
of MMTV-VEGF mice (
 
K
 
), whereas no hybridization signal is seen in the WT control mice (
 
L
 
).
 
 
 
VEGFR-1 is expressed around the duc-
tus epididymidis and inside the hyperplastic nodules (
 
arrowhead
 
) in TG mice (
 
M
 
) and it is also found in interstitial blood vessels (
 
ar-
row
 
). In WT mice (
 
N
 
) the mVEGFR-1 antisense probe recognizes only the interstitial blood vessels. Bars: (
 
AÐD
 
) 500 
 
m
 
m; (
 
E
 
, 
 
F
 
,
 
 I
 
,
 
 J
 
,
 
 
 
and
 
KÐN
 
), 50 
 
m
 
m; (
 
G and H), 10 mm. 
Figure 3. Aberrant spermato-
genesis in MMTV-VEGF
transgenic mice. Transil-
lumination analysis of sem-
iniferous tubules dissected
from the testis of a 6-mo-old
MMTV-VEGF mouse (top)
indicated that whereas some
tubules appeared normal (N),
the majority were homoge-
neously pale (P), lacking the
normal spermatogenic wave,
and some contained heavily
light absorbing hard material
(H). Squash preparation of
the pale segment (bottom)
shows that the spermatogen-
esis is interrupted at the elongation phase of the spermatids. Nor-
mal meiotic cell (M), step 9 spermatid (S), and apoptotic sper-
matocyte (A) are indicated. Bars: (top) 0.25 mm; (bottom) 10 mm.The Journal of Cell Biology, Volume 143, 1998 1710
Figure 4. Histological analysis of testes (AÐD) and localization of expression of the VEGF transgene and VEGFRs by in situ hybridiza-
tion (EÐL). Comparison of testes from a 6-mo-old MMTV-VEGF transgenic (A and C) and WT control mouse (B and D) indicates that
in the transgenic animals the rete testis (arrows) is dilated and the seminiferous tubules contain vacuoles and disorganized seminiferous
epithelium. The VEGF transgene is expressed in round spermatids (arrowhead) but not in Sertoli cells (arrow) as judged by in situ hy-
bridization with the hVEGF antisense probe (E, dark field; F and G, bright field). Asterisk, lumen of the seminiferous tubule. VEGFR-1Korpelainen et al. VEGF Regulates Male Fertility 1711
suggesting that they were upregulated by the overexpres-
sion of VEGF. This upregulation could depend on the di-
rect interaction of VEGF with small numbers of preexist-
ing VEGFRs in these cells, similar to what has been
described for autocrine VEGFR-2 upregulation in brain
endothelial cells exposed to hypoxia (21). In keeping with
our findings, VEGFR-1 and -2 have been recently de-
tected in the Leydig cells of human testes by immunohis-
tochemistry (9).
The epididymides of all MMTV-VEGF mice exhibited
epithelial hyperplasia in the cauda epididymidis. This re-
gional specificity may reflect the fact that the segments of
epididymis differ from each other not only morphologi-
cally but also functionally and biochemically (18, 26). It is
thus possible that the epithelium of the caudal part is more
responsive to the effects of the transgene. The level of
transgene expression was also higher in the hyperplastic
area than in the neighboring parts, suggesting that this
area may be more sensitive to signals activating the
MMTV promoter. These VEGF overexpressing areas ex-
hibited abnormal growth and permeability of capillaries,
which may be responsible for the hyperplasia of the ductal
epithelial cells. For example, the VEGF-stimulated endo-
thelium could provide mitogens for the epithelial cells in a
paracrine manner. On the other hand, the extravasation of
plasma proteins could contribute to the enhanced prolifer-
ation of the epithelial cells. The capillaries associated with
the epithelium expressed high levels of VEGFR-2 (and
VEGFR-1), whereas the nearby interstitial capillaries
remained VEGFR-2Ðnegative and seemingly unaffected.
VEGF overexpression therefore seems to have rather
short-range effects on the vascular network in the epididy-
mis, targeting mainly subepithelial capillaries. Also in the
testis VEGF mainly increased the capillary density, in con-
trast to other VEGF overexpression models where large
vessels or vascular sacs were seen (2, 35). It is possible that
the vascular effects of VEGF depend on the tissue context
where it is expressed.
The infertility of MMTV-VEGF male mice is probably
due to effects of VEGF on both the testis and the epididy-
mis. The finding of VEGFR-1 receptors in midpachytene
spermatocytes and round spermatids suggests that VEGF
can act directly on spermatogenic cells. The expression in
the round spermatids which are only beginning to elongate
is of particular interest as the observed spermatogenic ar-
rest occurred at this point. VEGF could affect spermato-
genesis also by acting on the Leydig cells, which are the
main source of testosterone. However, the testosterone
levels in testis homogenates and serum of MMTV-VEGF
mice were normal (data not shown). The vascular effects
of VEGF overexpression in testis could also contribute to
the infertile phenotype, as the increased capillary density
and size are likely to elevate the testicular temperature.
VEGF overexpression in the epididymis was associated
with increased vascular permeability as evidenced by ex-
travasation of fibrinogen resulting in intraepithelial and
intraluminal fibrin deposition. The increased permeability
may have important consequences especially in the caput
region, where a significant portion of the luminal fluid
from the testis is normally reabsorbed by the ductal epi-
thelium which is surrounded by a dense capillary network
(30). The reabsorption of fluid serves to concentrate the
sperm, improving its survival and maturation in the epi-
didymis. The importance of this function was recently
emphasized by the finding that oestrogen receptor-a
knockout (ERKO) mice are infertile due to defective epi-
didymal reabsorption (17). Notably, the ERKO mice ex-
hibited dilated rete testis and long-term atrophy of testes
due to back-pressure of the luminal fluid (8). The aberra-
tions seen in the testes of MMTV-VEGF males could thus
be, at least partly, due to the effect of VEGF on vascular
permeability in the epididymis. In keeping with this possi-
bility, VEGF has been recently shown to increase the
number of fenestrations, transendothelial gaps, and trans-
cytotic vesicles in the endothelium of epididymal capillar-
ies (10). Defective fluid reabsorption could lead to the ob-
served swelling of the ductus epididymidis. Alternatively,
the swelling could be a consequence of ductal occlusion by
the hyperproliferation of the caudal epithelium.
Taken together, our present results show that overex-
pression of VEGF under the MMTV LTR promoter in the
testis and epididymis of transgenic mice results in infertil-
ity, probably via the effects of VEGF on both endothelial
and nonendothelial cells of the male genital tract. It is
striking that although over 30 different transgenes includ-
ing various (proto)oncogenes have been expressed under
antisense probe recognizes midpachytene spermatocytes and round spermatids in stage VIII seminiferous tubules of the WT mice (K,
dark field; L, bright field) and also Leydig cells in the testis of the MMTV-VEGF mice (H, dark field; I, bright field). The area enclosed
within the rectangle in I is shown at higher magnification in J. Leydig cell (arrow), round spermatid (arrowhead), midpachytene sperma-
tocyte (open arrowhead), and a capillary (asterisk) are indicated. VEGFR-2 signal is detected in the Leydig cells of the MMTV-VEGF
mice (N), whereas the testis of a WT control mouse does not show any hybridization with the VEGFR-2 antisense probe (M). Bars: (A
and B), 500 mm; (C and D) 100 mm; (E, F, H, I, and KÐN) 50 mm; (G and J) 10 mm.
Table I. Summary of the Cell Types Expressing VEGF and Its Receptors in the Testis and Epididymis of WT and MMTV-VEGF 
Transgenic Mice as Judged by In Situ Hybridization
Testis Epididymis
VEGF Round spermatids (TG only) Ductal epithelium (TG only)
VEGFR-1 Round spermatids Endothelial cells of interstitial blood vessels
Midpachytene spermatocytes
Leydig cells (TG only) Endothelial cells of capillaries within the hyperplastic epithelium (TG only)
VEGFR-2 Leydig cells (TG only) Endothelial cells of capillaries within the hyperplastic epithelium (TG only)The Journal of Cell Biology, Volume 143, 1998 1712
the MMTV LTR, only one of them, the constitutively ac-
tive oncogenic mutant of the Neu tyrosine kinase receptor,
caused epithelial hyperplasia of the epididymis resulting in
infertility (3, 23). However, the MMTV-neu males were
fertile until 3Ð4 mo of age (3), whereas the MMTV-VEGF
males never sired any litters. The dramatic phenotype of
the MMTV-VEGF males is of interest as recent studies
have reported detection of VEGF and its receptors in the
human testis, epididymis, seminal vesicle, and prostate tis-
sues, and high VEGF concentrations in semen (4, 9, 10).
Although the exact functions of VEGF in the male genital
tract remain to be elucidated, it is likely to play an impor-
tant role in male fertility. It should be noted that systemic
inhibition of VEGF function in female rats using a recom-
binant soluble VEGFR-1 curtails corpus luteum develop-
ment (12). The striking finding that VEGF has nonendo-
thelial target cells in the testis should make it possible to
study and perhaps even to manipulate the reproductive
functions of VEGF in males.
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